StockData
HSICNasdaqWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 26

HENRY SCHEIN INC

Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Aug 4, 2026
$83.97−2.41 (-2.79%)

Close on Oct 19, 2026

Market cap
$9.61B
P/E (TTM)
24.5
Dividend yield
–

About Henry Schein

Wholesale-Medical, Dental & Hospital Equipment & Supplies, SIC 5047

The company operates through three principal business segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. Within its primary distribution operations, the business provides dental merchandise, dental equipment, and specialized value-added services, alongside a dedicated medical distribution unit. Its offerings serve healthcare practitioners and organizations requiring specialized dental and medical products, equipment, and related operational support solutions.

Geographically, the entity divides its operational reporting between domestic activities within the United States and international markets designated as non-U.S. regions. The provided filing text details jurisdictional operations spanning state, local, and foreign regions, but does not identify the specific location of its corporate headquarters or quantify its physical footprint, store network, or facility locations.

Summary of the business section of Henry Schein's latest annual report, written by StockData.

Company profile

Company

Legal name
HENRY SCHEIN INC
Founded
1932
Headquarters
Melville, NY
Address
135 Duryea Rd 11747
Phone
(631) 843-5500
Employees
25,000, Dec 27, 2025
Industry
Wholesale-Medical, Dental & Hospital Equipment & Supplies
Incorporated in
Delaware
Fiscal year ends
December 26
Auditor
BDO USA, P.C., New York, New York

Stock & identifiers

Ticker
HSIC
Exchange
Nasdaq
IPO date
Nov 3, 1995
Shares outstanding
111M, Jul 27, 2026
Public float
$8.89B, Jun 28, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Nov 6, 2017; 2-for-1, Sep 15, 2017; 2-for-1, Mar 1, 2005
SEC CIK
1000228
CUSIP
806407102
ISIN
US8064071025
LEI
VGO3WGL8H45T73F4RR92
EIN
11-3136595

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Frederick M. LoweryCEO, Director95,156
Andrea AlbertiniCEO, Global Dist. & Tech.116,104
Kelly Ann MurphySVP & General Counsel34,812
Thomas C. PopeckCEO, Henry Schein Products86,182
Ronald N. SouthSVP & Chief Financial Officer88,930
Michael S. EttingerEVP & Chief Operating Officer112,418
Mark E. MlotekEVP, Chief Strategic Officer109,874
Christine Zayac SheehySVP, Chief Human Res. Officer18,454
Bradford C. ConnettCEO, NA Distribution Group62,688
James P. BreslawskiPresident200,227
Walter SiegelSr. VP & Chief Legal Officer43,191
William K. DanielDirector27,641
Kurt P. KuehnDirector15,420
Bradley T. ShearesDirector47,623
Robert J. HombachDirector5,421
Philip A. LaskawyDirector24,538
Reed Vaughn TucksonDirector12,520
Joseph L. HerringDirector31,859
Anne H. MarguliesDirector23,153
Mohamad AliDirector15,075
Deborah DerbyDirector15,853
Scott Philip SerotaDirector11,790
Carole T. FaigDirector8,025
Carol RaphaelDirector33,538
Max LinDirector0

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Mr. Bergman
$12.01M$9.78M$3.29M$116$144
FY2024
Mr. Bergman
$11.64M$7.85M$3.19M$107$126
FY2023
Mr. Bergman
$10.01M$4.94M$2.81M$115$122
FY2022
Mr. Bergman
$8.26M$9.96M$2.95M$121$120
FY2021
Mr. Bergman
$10.79M$28.29M$3.85M$114$124
FY2020
Mr. Bergman
$6.24M-$8.38M$2.65M$99$114

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“and employ more than 25,000 people.”

Corporate history

Events identified from SEC filings